Northwestern Sells Drug Royalty Rights For $700M
Northwestern University has sold part of its royalty rights to the pain therapy Lyrica to Royalty Pharma for $700 million in cash, the largest sale of its type yet made....To view the full article, register now.
Already a subscriber? Click here to view full article